^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tigatuzumab (CS-1008)

    i
    Associations
    News
    Trials
    Company:
    Daiichi Sankyo
    Drug class:
    TRAIL R2 agonist
    Related drugs:
    Associations
    News
    Trials